QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (33) Citing Articles via Google Scholar Google Scholar Articles by Hurley, R. W. Articles by Hammond, D. L. Search for Related Content PubMed PubMed Citation Articles by Hurley, R. W. Articles by Hammond, D. L. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB NALTREXONE Medline Plus Health Information Pain

 Previous Article  |  Next Article 

The Journal of Neuroscience, April 1, 2001, 21(7):2536-2545

Contribution of Endogenous Enkephalins to the Enhanced Analgesic Effects of Supraspinal µ Opioid Receptor Agonists after Inflammatory Injury

Robert W. Hurley and Donna L. Hammond

Department of Anesthesia and Critical Care and The Committee on Neurobiology, University of Chicago, Chicago, Illinois 60637

This study examined a mechanism responsible for the enhanced antihyperalgesic and antinociceptive effects of the µ opioid receptor agonist (ORA) [D-Ala², NMePhe⁴, Gly⁵-ol]enkephalin (DAMGO) microinjected in the rostroventromedial medulla (RVM) of rats with inflammatory injury induced by injection of complete Freund's adjuvant (CFA) in one hindpaw. In rats injected with CFA 4 hr earlier, microinjection of the µ opioid receptor antagonist D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH₂ (CTAP) in the RVM antagonized both the marginal enhancement of the potency of DAMGO and its antinociceptive effect. The  opioid receptor antagonist naltriben (NTB) was without effect. In rats injected with CFA 2 weeks earlier, CTAP antagonized the effects of DAMGO to a lesser extent. However, NTB completely prevented the enhancement of the potency of DAMGO, whereas it did not antagonize DAMGO's antinociceptive effects. Microinjection of NTB alone, but not CTAP in the RVM of CFA-treated rats, enhanced the hyperalgesia present in the ipsilateral hindpaw and induced hyperalgesia in the contralateral, uninjured hindpaw. These results suggest that persistent inflammatory injury increased the release in the RVM of opioid peptides with preferential affinity for the  opioid receptor, which can interact in a synergistic or additive manner with an exogenously administered µ opioid receptor agonist. Indeed, the levels of [Met⁵]enkephalin and [Leu⁵]enkephalin were increased in the RVM and in other brainstem nuclei in CFA-treated rats. This increase most likely presents a compensatory neuronal response of the CNS of the injured animal to mitigate the full expression of inflammatory pain and to enhance the antinociceptive and antihyperalgesic effects of exogenously administered µ opioid receptor analgesics.

Key words: µ opioid receptor; opioid receptor; antinociception; complete Freund's adjuvant; hyperalgesia; nucleus raphe magnus

---

Copyright © 2001 Society for Neuroscience  0270-6474/01/2172536-10$05.00/0

This article has been cited by other articles:

				K. M. Hellman, T. S. Brink, and P. Mason Activity of Murine Raphe Magnus Cells Predicts Tachypnea and On-Going Nociceptive Responsiveness J Neurophysiol, December 1, 2007; 98(6): 3121 - 3133. [Abstract] [Full Text] [PDF]

				K. T. Sykes, S. R. White, R. W. Hurley, H. Mizoguchi, L. F. Tseng, and D. L. Hammond Mechanisms Responsible for the Enhanced Antinociceptive Effects of {micro}-Opioid Receptor Agonists in the Rostral Ventromedial Medulla of Male Rats with Persistent Inflammatory Pain J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 813 - 821. [Abstract] [Full Text] [PDF]

				X. Wang, R. J. Traub, and A. Z. Murphy Persistent pain model reveals sex difference in morphine potency Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2006; 291(2): R300 - R306. [Abstract] [Full Text] [PDF]

				Y. Guan, J. Borzan, R. A. Meyer, and S. N. Raja Windup in dorsal horn neurons is modulated by endogenous spinal mu-opioid mechanisms. J. Neurosci., April 19, 2006; 26(16): 4298 - 4307. [Abstract] [Full Text] [PDF]

				W. Kincaid, M. J. Neubert, M. Xu, C. J. Kim, and M. M. Heinricher Role for Medullary Pain Facilitating Neurons in Secondary Thermal Hyperalgesia J Neurophysiol, January 1, 2006; 95(1): 33 - 41. [Abstract] [Full Text] [PDF]

				S. N. Sterious and E. A. Walker Potency Differences for D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 as an Antagonist of Peptide and Alkaloid {micro}-Agonists in an Antinociception Assay J. Pharmacol. Exp. Ther., January 1, 2003; 304(1): 301 - 309. [Abstract] [Full Text] [PDF]

				K. Miki, Q.-Q. Zhou, W. Guo, Y. Guan, R. Terayama, R. Dubner, and K. Ren Changes in Gene Expression and Neuronal Phenotype in Brain Stem Pain Modulatory Circuitry After Inflammation J Neurophysiol, February 1, 2002; 87(2): 750 - 760. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help